Highlights From ATS 2025: New and Emerging Therapies, Biomarkers, and Imaging for ILDs

from Medical News Podcast · host PeerDirect Publishing

Drs. Zaman and Podolanczuk discuss data for new and emerging therapies for ILD presented at ATS 2025, including nerandomilast, inhaled therapies for IPF and ILD, TNIK inhibitors, as well as new biomarkers and imaging for diagnosing ILDs.

Episode metadata supplied by the publisher feed · Published Jun 27, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Highlights From ATS 2025: New and Emerging Therapies, Biomarkers, and Imaging for ILDs

0:00 13:58

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical News Podcast?

This episode is 13 minutes long.

When was this Medical News Podcast episode published?

This episode was published on June 27, 2025.

Can I download this Medical News Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!